Tenet Healthcare Corp. 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended August 31, 1997, for Tenet Healthcare Corporation, a Nevada corporation operating general hospitals and related healthcare businesses. As of September 30, 1997, there were 305,243,588 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 1997 | Q2 1996 |
|---|---|---|
| Net Operating Revenues | $2,331 million | $1,991 million |
| Operating Income | $305 million | $261 million |
| Net Income | $116 million | $96 million |
| Earnings Per Share | $0.38 | $0.32 |
| Operating Margin | 13.1% | 13.1% |
| Cash and Cash Equivalents | $103 million | $122 million (end of period) |
| Working Capital | $782 million | $522 million (May 31, 1997) |
| Total Debt (Current + Long-term) | $5,315 million | $5,050 million (May 31, 1997) |
| Unused Borrowing Capacity | $1.7 billion | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 17.1% to $2,331 million, driven by acquisitions and volume growth. Domestic general hospital revenues rose to $2,123 million.
- Profitability: Net income increased 20.8% to $116 million. Operating income grew 16.9% to $305 million.
- Acquisitions: The company acquired four general hospitals and several healthcare businesses during the quarter. A subsequent acquisition of a general hospital for approximately $263 million was announced on September 5, 1997.
- Volume Statistics: Admissions increased 15.0% to 205,572, and outpatient visits rose 16.9% to 2,652,213. However, net inpatient revenues per patient day decreased 3.9% to $1,272.
- Expense Trends: Salaries and benefits rose to 41.4% of revenues (from 41.0%), and the provision for doubtful accounts increased to 6.3% (from 5.6%) due to shifts in payer mix and aging receivables.
- Cash Flow: Net cash provided by operating activities was $1 million, significantly lower than the $87 million in the prior year, primarily due to $165 million in cash expenditures charged against reserves for discontinued operations and non-recurring charges.
Guidance, Outlook, and Risks
- Regulatory Impact: Management anticipates that changes in Medicare reimbursement mandated by the Balanced Budget Act of 1997 (effective October 1, 1997) will reduce payments. However, the company does not expect a material adverse effect on results of operations.
- Managed Care: The percentage of revenues from managed care payors increased to 32.3% from 28.0%. The company expects this trend to continue, noting that managed care payors generally provide lower payments than traditional indemnity insurers.
- Capital Expenditures: The company expects to spend approximately $400 million to $500 million annually on capital expenditures, excluding significant acquisitions and an estimated $355 million commitment for two new hospitals.
- Liquidity: Management believes cash from operations and $1.7 billion in unused credit facility capacity are adequate to meet debt service and financing needs for the next 18 months to three years.
- Risks: Key risks include healthcare reform legislation, payor pressure to reduce admissions and lengths of stay, increased competition, and the company's significant indebtedness.
Investor Verification Checklist
- Verify the impact of the Balanced Budget Act of 1997 on Medicare reimbursement rates effective October 1, 1997.
- Confirm the integration and financial performance of the four hospitals acquired during the quarter and the $263 million acquisition announced in September.
- Monitor the trend in the provision for doubtful accounts (6.3% of revenue) and the aging of accounts receivable.
- Assess the company's ability to maintain debt covenants, specifically the requirement for senior long-term unsecured debt to be rated BBB- or higher to pay dividends or repurchase stock.
- Review the $165 million in non-recurring charges related to discontinued operations to understand their nature and future recurrence.